Who has invested in NeoCura?

CDH, PICC Capital Investment Management, Jiayin Fund are named among the investors backing NeoCura.

NeoCura Funding: $38M Raised, Series A (2021)

NeoCura funding overview

NeoCura is based in Beijing, China. NeoCura has raised $38M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in December 2021. The round record for NeoCura runs through 2021; nothing later has been disclosed. Investors on record include CDH, PICC Capital Investment Management, Jiayin Fund. 3 distinct backers are named across the disclosed rounds.

NeoCura at a glance

Total raised: $38M
Latest round: Series A
Latest round date: December 2021
Headquarters: Beijing, China
Notable investors: CDH, PICC Capital Investment Management, Jiayin Fund

Frequently asked about NeoCura funding

How much has NeoCura raised?: NeoCura has raised $38M in total disclosed funding across the rounds on record.
Who has invested in NeoCura?: CDH, PICC Capital Investment Management, Jiayin Fund are named among the investors backing NeoCura.
What was the latest NeoCura funding round?: The most recent disclosed round is a Series A, announced in December 2021.
Where is NeoCura based?: NeoCura is based in Beijing, China.
When did NeoCura last raise?: The last disclosed NeoCura round closed in December 2021 at Series A.

NeoCura totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Beijing below to benchmark round size and investor mix.

NeoCura Funding: $38M Raised, Series A (2021)

NeoCura funding overview

NeoCura at a glance

Frequently asked about NeoCura funding

Companies related to NeoCura (23)

Browse related funding lists (5)